Areas of Work
The ACT-Accelerator partnership is structured around the three pillars of Diagnostics, Therapeutics and Vaccines (COVAX), with a cross-cutting Health Systems and Response Connector (HSRC) and Access and Allocation workstream.
The co-convening agencies of the ACT-Accelerator are: CEPI, FIND, Gavi, The Global Fund, UNICEF, Unitaid, Wellcome, WHO, the World Bank and The Bill & Melinda Gates Foundation. The agencies work closely with governments, scientists, businesses, civil society, and philanthropists.
The Vaccines Pillar, COVAX, supports countries’ needs and own goals to control the disease and reopen society in 2022 and beyond, contributing towards the 70% global vaccination target in 2022.
COVAX is convened by CEPI, Gavi and WHO. UNICEF is global delivery partner, with PAHO covering the Americas.
The Therapeutics Pillar supports access to safe and effective therapeutics of assured quality to save millions of lives from COVID-19 and to minimise its global health and economic threat.
The therapeutics pillar is co-led by Unitaid, the Global Fund and Wellcome.
The Diagnostics Pillar has an overall objective to significantly increase access to COVID-19 tests and sequencing, which will ensure effective test, trace, isolate, and treat strategies, as well as early identification and containment of new variants.
The pillar is co-convened by the Global Fund and FIND,
The Health Systems & Response Connector (HSRC) ensures all countries have the necessary technical, operational and financial resources to translate new COVID-19 tools into national response interventions to stop transmission and save lives.
HSRC is co-convened by the Global Fund, World Bank and WHO, with UNICEF.